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The Effect of Growth Factors on the Corneal Stroma Extracellular Matrix
Production by Keratocyte
LaTia Shaquan Etheredge
ABSTRACT
The corneal wound healing process is a complex process, which often
leads to the development of scar tissue with loss of transparency. When the
cornea is wounded, some of the viable keratocytes are activated by growth
factors to proliferate, and repair the wound by the production of a new
extracellular matrix (ECM) that is either normal or is disorganized (fibrotic). The
first part of this dissertation aims to show that the growth factors IGF-I, TGF-β,
FGF-2, and PDGF stimulate keratocytes to synthesize different levels of
collagens and proteoglycans and are therefore responsible for initiating the
wound healing repair process. FGF-2 stimulated keratocytes to proliferate but
did not stimulate collagen production; IGF-I and PDGF stimulated keratocytes to
proliferate and produce a collagenous ECM that could restore transparency;
while, TGF-β stimulated keratocytes produce a fibrocollagenous ECM that is
opaque.
The second part of this dissertation aims to evaluate collagen fibril
content, distribution, and orientation in the ECM deposited by keratocytes
cultured in IGF-I, TGF-β, FGF-2, and PDGF under a layer of agarose: a culture
vi

modification that enhances the formation of ECM in vitro. FGF-2 agarose
cultures had little ECM and the keratocytes were in close cell contact while IGF-I,
TGF-β, and PDGF agarose cultures had the least cell contact with an extensive
fibrillar ECM. This newly developed agarose overlay cell culture system
increases ECM formation with the cell layer only when the synthesis of collagen
is stimulated and that the ECM morphology is growth factor specific.
Cell culture has proven to be a reliable technique to study the keratocytes
response to trauma and disease; however, limitations exist. Primary keratocytes
that possess quiescent phenotype are unable to be rapidly expanded or
subcultured without the addition of a mitogen(s). Most commonly, keratocytes
are cultured and passaged in the presence of fetal bovine serum (FBS), which
activate the cells to proliferate and differentiate into fibroblasts or myofibroblasts
as well as lose expression of their unique transparency enabling gene products.
The third part of this dissertation aims to develop a defined culture media that
can be used to expand and subculture keratocytes that express keratocyte
specific markers. Culture medium supplemented with FGF-2 combined with ITS
was used to: expand and subculture primary bovine keratocytes while
maintaining their expression of keratocan and to restore keratocan expression to
bovine keratocytes expanded and subcultured with media containing 2.5% FBS.
This dissertation shows the significance of signaling molecules in vitro to
produce keratocyte cultures useful for understanding normal stromal biology and
its repair process.

vii

Chapter One
Introduction
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The Cornea
The cornea is a uniquely transparent structure that has a powerful
refractive surface, which produces 2/3 of the eye's total focusing power (Fig. 1).
The cornea is void of blood supply; therefore it receives its nutrients by diffusion
from the tear fluid and aqueous humour. In humans, the cornea has a thickness
of 0.5-0.8mm and a diameter of about 11.5mm. The cornea is made up of three
distinct cellular layers that are separated by basement membranes (Fig. 2) [see
reviews [1, 2]. The epithelial layer is the outermost region that functions as a
barrier and to absorb oxygen and other cell nutrients located in the tear fluid.
The stroma is the thickest layer and functions to provide the cornea with strength
and shape. It is separated from the epithelium anteriorly by bowman’s membrane
and from the endothelium posteriorly by descemet’s membrane, both of which
are acellular. The endothelial layer is a single layer of cells that pumps excess
fluid out of the stroma. All of these layers work together to transmit and refract
light on the surface of the retina.
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Figure 1. Cornea in relationship to the eye. * Wilson, S.A. and A. Last,
Management of corneal abrasions. Am Fam Physician, 2004. 70(1): p. 123-8.

Figure 2. Anatomy of the cornea. * Wilson, S.A. and A. Last, Management of
corneal abrasions. Am Fam Physician, 2004. 70(1): p. 123-8.
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Development of the Cornea
Corneal morphogenesis results from a sequence of controlled
developmental events. In some lower vertebrates, the corneal epithelium
secretes and assembles a primary stroma that is acellular and contains collagen
types II, IX, and I. The primary stroma is composed of one or two layers of
orthogonal layers of fibrils and has been shown to serve as a template for the
subsequent invasion of neural crest cells that differentiate into keratocytes. The
presumptive keratocytes proliferate and synthesize the secondary or mature
stroma. The development of the mature stroma is initiated by the swelling of the
primary stroma that is triggered by the removal of collagen type IX from the
primary stroma and the production of hyaluronic acid. The stroma then
undergoes dehydration and compaction; thus the extracellular (ECM)
components of the stroma become more concentrated, resulting in the highly
organized and uniform array of collagen fibrils that is transparent. The mature
stroma primarily consists of collagen types I and V, and proteoglycans.

ECM Components of the Mature Cornea
The transparency of a mature cornea is mostly attributed to the cornea
stroma, which constitutes 90% of the mature corneal thickness. The cornea
stroma is comprised of a highly organized, uniquely transparent ECM, sparsely
populated with keratocytes. The ECM is composed primarily of collagen types I
and V and two major types of small leucine-rich proteoglycans; chondroitin
sulfate (decorin) and keratan sulfate (lumican and keratocan) [2]. The collagen
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fibrils present in the corneal stroma are heterotrophic and are arranged in
alternate layers and are separated by proteoglycans [3, 4]. The small size of the
proteoglycans determines the spacing of fibrils and the core proteins of the
proteoglycans and collagen type V regulate the fibril diameter [5, 6]. Embedded
in the corneal collagenous matrix are keratocytes. They account for 2.4% of the
stromal volume and are responsible for the ECM production. They are
characterized by a dendritic morphology and form a three-dimensional network
by contact with their extensive processes [7-9].

Collagen
Collagen is the most abundant protein in vertebrate corneas and makes
up approximately 80% of the total corneal protein. There are three major
families of collagens: fibril-forming collagens, fibril-associated collagens with
interrupted triple helices, and nonfibrillar collagens. The collagen stroma
contains collagen types I and V, which are fibril-forming and the basement
membrane of the epithelium and endothelium contains collagen type IV, which is
a non-fibril forming collagen. Although there are differences among collagens,
they all contain regions where a glycine is every third residue and are comprised
of 3 polypeptide chains [10].
These chains undergo extensive post- translational modifications such as
hydroxylation, glycosylation, and disulfide formation [11]. The hydroxylation of
selected proline and lysine residues is necessary to stabilize the triple helical
regions and ascorbate is co-factor needed for hydrolylation [12].
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The disulfide bonds aid in aligning the modified polypeptide chains and initiate
the formation of the triple helix starting at the C-terminal end. The resultant
procollagen molecule is comprised of a triple helical domain, which is 33%
glycine and non helical N- and C-terminal globular regions [11]. The procollagen
N- and C-propeptides are cleaved by enzymes: a procollagen N-proteinase and
procollagen a C-proteinase, respectively, producing collagen molecules that
associate into collagen fibrils [13]. These collagen fibrils are the major
components of most ECMs.

Proteoglycans
Proteoglycans are also part of most ECMs and are associated with
collagen fibrils. Proteoglycans are composed of a core protein with covalently
linked glycosaminoglycan (GAG) chains via serine residues.
Glycosaminoglycans are linear, repeated disaccharides that are usually sulfated
and have a molecular weight of 10-100 kDA. Hyaluronan is an unsulfated GAG.
Sulfated GAGs are chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin
sulfate, and heparan sulfate. Proteoglycans are classified by their core proteins
and are grouped into three major families: modular, cell-surface, and small
leucine-rich proteoglycans (SLRPs).
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Modular proteoglycans contain large core proteins comprised of multiple
and often repeating subunits and can be highly glycosylated [14]. These can be
further divided into two subfamilies: hyalectans (versican, aggrecan, neurocan,
and brevican), which bind hyaluronan, and lectin-binding proteoglycans (perlican,
agrin, and testican). The cell-surface proteoglycans are also divided into two
subfamilies: core proteins with a membrane-spanning domain (syndecan) and
with a glycosyl-phosphatidylinositol (GPI) linkage (glypican). The SLRPs are
characterized by tandem arrays of leucine-rich repeats and the presence of at
least one GAG side chain (Fig. 3) [15]. There are two subfamilies of SLRPs:
dermatan/chondroitin sulfate (decorin and biglycan) and keratan sulfate (lumican,
keratocan, and fibromodulin) proteoglycans. Lumican and keratocan are
important for the transparency of the cornea by regulating the spacing and
diameter of the collagen fibrils [5, 6, 16].

Figure 3. Small leucine-rich proteoglycan (SLRP) structure
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Growth Factors and Receptors
Growth factors are cell-secreted soluble proteins that bind receptors on
the cell surface of the same cell or in other cells [17]. There are two families of
cell surface receptors: receptor tyrosine kinase and G-protein-coupled receptor
[18]. Both the receptor and growth factor may have multiple isoforms that have
different binding affinities and functions [17]. The binding of growth factors to
their respective receptors can promote the proliferation, migration, differentiation,
or survival of cells during development, tissue repair, and pathologies. The effect
of growth factors can vary depending on when it is activated, in which cell type is
it produced, and how it interacts with other factors such as extracellular matrix
components.
There are many different growth factors and the research conducted in
this thesis has focused on insulin-like growth factor (IGF-I), transforming growth
factor-beta (TGF-β), Fibroblast growth factor-2 (FGF-2), platelet derived growth
factor (PDGF). IGF-I and FGF-2 are single chain polypeptides. IGF-I has a 50%
amino acid homology to insulin and IGF-2, and it binds to the IGF-I receptor [18].
FGF-2 belongs to the heparin-binding growth factor family. FGF-2 is composed
of 146 amino acids and binds with a low affinity to heparin and heperan- sulfate
proteoglycans. This association prevents the growth factor from being degraded
and increases the affinity for 1 of 4 cell surface receptors (FGFR1-4) for FGF-2.
Unlike IGF-I and FGF-2, PDGF is a dimer composed of two polypeptide
chains, A and B, which can form three different isoforms (PDGF-AA, PDGF-AB,
and PDGF-BB). The A and B polypeptide chains are approximately 100 amino
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acid residues long and have a 60% amino acid homology [19]. These proteins
are cleaved intracellularly and are secreted in their active forms [19]. Each of
these isoforms can bind to the alpha-receptor but PDGF-BB is the only isoform
that can bind to the beta-receptor.
There are three homodimeric mammalian isoforms of TGF-beta [20] that
are 60-80% homologous. The most characterized member of the family of TGFbeta proteins is TGF-beta 1. TGF-beta is synthesized as a precursor protein that
requires activation into a mature form for receptor binding and subsequent
activation of signal transduction pathways. The TGF-beta family can bind to
three membrane receptors: RI, RII, and RIII.
IGF-I, FGF-2, and PDGF act through receptor tyrosine kinases by binding
simultaneously to two receptor chains. After binding, the receptors and
sometimes the ligands themselves are phosphorylated on tyrosines, thus may
initiate multiple intracellular signaling pathways. The major pathway associated
with these growth factors is mitogen-activated protein kinase (MAP-Kinase).
TGF-beta is slightly different because it acts through receptor serine/threonine
kinases by activating a type-II receptor that recruits, phosphorylates, and activate
type-I receptor; thus initiating the Smad-dependent signaling pathway.

Wound Healing Overview
There are three major phases of the wound healing process:
inflammatory phase, the proliferative phase, and the remodeling phase [21, 22].
The inflammatory phase begins immediately after wounding by the invasion of
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lymphocytes and macrophages and is characterized by the clotting cascade.
The cells that make up the clot and the invading cells release growth factors and
cytokines such as PDGF and TGF-β [21-23]. Subsequently, the proliferative
phase begins as invading fibroblasts proliferate and synthesize a new ECM [21].
During the final remodeling phase, there is an increase in ECM production and
breakdown. The recently formed ECM becomes more organized and crosslinked, eventually providing approximately 80% of the strength of the uninjured
tissue [22].

Corneal Wound Healing
The cornea’s ability to remain transparent can be compromised when the
cornea encounters trauma, infection, ulceration, and other pathologies. The
wound repair process of the cornea is similar to skin, tendon, and other tissue
types; however, the distinct avascular nature and the uniquely organized ECM of
the cornea cause differences in the mechanism [24, 25].
In a healthy cornea, there are very few resident inflammatory cells present
[26, 27] but they have been shown to infiltrate the corneal stroma immediately
after wounding [28, 29]. These cells along with the lacrimal gland, the
epithelium, and the native stromal cells (keratocytes) produce the growth factors
that are supplied to the site of injury [30]. Upon wounding, TGF-beta and IL-1
are released from the disrupted epithelium into the stroma. IL-1 has been shown
to promote apoptosis of damaged keratocytes and keratocytes flanking the
wound [31]. In addition, IL-1 increases the production of PDGF and other growth
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factors, and activates neutrophils, which are cells that clear the wound site of
invading bacteria and cellular debris [32]. Metalloproteinases are also released
to further clear the wound site by degrading collagen, proteoglycans, and other
ECM proteins [33, 34].
The initial stromal apoptosis and ECM degradation in the cornea is
followed by the activation, proliferation, and migration of the remaining viable
keratocytes into the depleted stroma, to begin to replenish the stroma. Some of
the activated keratocytes are initiated by growth factors to transition into
divergent phenotypes. FGF-2 has been found to cause keratocytes to become
more spindle-shaped [35], increase their proliferation and migration [20], and
promote keratan sulfate proteoglycan synthesis [35]. TGF-beta causes
keratocytes to become myofibroblasts, which are associated with a highly fibrotic
wound phenotype. These cells are characterized by decreased transparency,
which is associated with the reduction of corneal crystallins and the expression of
the cytoplasmic protein alpha smooth muscle actin [36]. Studies have shown
that TGF-beta also stimulates the production of additional growth factors,
collagen and other proteins associated with the remodeling of the ECM [37].
IGF-II has been shown to be a normal component of the stromal ECM and to be
made by keratocytes during corneal development [38, 39].
The remodeling of the corneal stroma can end in corneal fibrosis or
restoration of corneal transparency. It has been proposed that an altered ratio of
collagen types I and V, an altered expression of proteoglycans in the wounded
corneal stroma, and a decrease in corneal crystallin production by keratocytes
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may be responsible for the opacity. The reason that injured keratocytes fail to
regenerate a well-organized ECM remains unknown. It is probable that growth
factors play an important role in regulating the expression of the genes needed
for both wound healing and restoration of transparency.

Causes of Blindness
In 2004, approximately 3.6 million Americans suffered from blindness and
vision impairment [40]. Diseases of the cornea represent a significant cause of
blindness and vision impairment and have been shown to be the second leading
cause of blindness in children [41, 42]. In the United States, corneal disease
accounts for 0.7% of total number of new incidence of blindness, however,
ophthalmic treatment of diseases affecting the cornea accounts for 25% [41].
Keratoconus is a non-inflammatory eye disease where the cornea
develops a conical shape. Keratoconus is characterized by the thinning of the
corneal stroma and is typically manifested during puberty. In the general
population, reported incidence are approximately 1 per 2000 [43]. In
keratoconus corneas, the thickness of lamellae is unaltered, but the number of
lamellae is less in normal tissue [44]. Additionally, proteoglycans and keratocyte
density are reduced in keratoconus corneas when compared with normal
corneas. The biochemical analysis of the stromal matrix of the keratoconus
cornea remains inconclusive.
In developed countries, less than 2% of blindness is caused by corneal
disease in children, while in the poor areas of Asia and Africa 25-50% attributed
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to corneal scarring [45]. Eye injuries are another cause of blindness leaving 1.6
million people blind, 2.3 million people with bilateral vision impairment, and 19
million with unilateral blindness or vision impairment [46]. Approximately,
750,000 of these eye injury cases will require hospitalization each year [46].
Overall, blindness and vision impairment is a growing economical concern, with
the projected increase of about 70% by 2020 [1].

Outline
Corneal wound healing is a complex process of events that occurs as a
result of the synthesis of new ECM proteins. The ECM components produced
during corneal wound healing can aid in regeneration or induce scar formation
which is characterized by a disorganized corneal stroma ECM [47]. The reason
that injured corneas fail to regenerate a normal stroma remains unknown. It has
been proposed that keratocytes produce an altered ratio of collagen types [48,
49] and have an altered expression of proteoglycan types [49, 50]. However,
these changes alone cannot fully explain corneal wound healing and the
subsequent scar formation. It is probable that the absence or presence of other
ECM components, may contribute to the disorganized and opaque corneal
stroma.
There are four phases of corneal wound healing: inflammation phase,
proliferation phase, hypercellular phase, and matrix remodeling phase. Growth
factors are produced primarily during the inflammation phase by lymphocytes
and macrophages that invade the wound. We hypothesize that the subsequent
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phases of corneal wound healing are stimulated by specific growth factors that
stimulate keratocytes to proliferate and produce a specific ECM. We also
propose that these different phases of corneal wound healing can be replicated
in vitro by culture in serum free media containing growth factors.
Studies have shown that TGF-β, FGF-2, and PDGF can be found in tear
fluid where they could act on keratocytes exposed by wounds and can be made
by the invading lymphocytes and macrophages [51, 52]. TGF-β and FGF-2 have
also been found in corneal wounds [53]. IGF-II and IGF-I have been shown to be
present in the normal corneal stroma [39].
Therefore we will use serum free media containing IGF-I, TGF-β, FGF-2,
and PDGF to activate keratocytes in vitro. Then, we will characterize the level of
proliferation and ECM synthesis produced by the action of these growth factors
on keratocytes and compare this to the levels of proliferation and ECM synthesis
seen in vivo during the hypercellular and ECM matrix restoration phases of
corneal stroma wound healing. As a result of this approach, we expect to be
able to identify the growth factors that stimulate the different phases of corneal
wound healing and replace the question marks shown in [Fig. 4] with specific
growth factors.
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Figure 4. Phases of corneal stromal wound healing.

Specific Aims
The remainder of this dissertation will present the findings of my research
project of understanding the effect of IGF-I, TGF-β, FGF-2, and PDGF on corneal
stroma ECM production by keratocytes. My first specific aim was to determine if
insulin and IGF-I have the same effect on keratocyte proliferation and on ECM
synthesis. This data is discussed in the Appendix. My second specific aim was
evaluate the effect of IGF-I, TGF-β, FGF-2, and PDGF to stimulate keratocytes to
proliferate and produce different ECM components. These findings are
summarized in Chapter Two. My third specific aim was to evaluate collagen
fibrils produced by keratocyte cultures in growth factors by using a novel agarose
overlay cell culture system. These findings are summarized in Chapter Three.
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My fourth specific aim was to develop a defined culture medium that can be used
to expand and subculture keratocytes that express keratocyte specific markers.
These findings are summarized in Chapter Four. A brief discussion of the major
findings of my dissertation research is found in Chapter Five.
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Chapter Two
The effect of growth factor signaling on keratocytes in vitro and its
relationship to the phases of stromal wound repair
LaTia Etheredge1*, Bradley P. Kane2, John R. Hassell1,2

Departments of Pathology and Cell Biology1 and Molecular Medicine2
College of Medicine
University of South Florida
Tampa, FL

Published in Investigative Ophthalomlogy & Visual Science 2009 July; 50(7):
3128-3136
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Abstract
Purpose: To determine the relationship between signaling by different growth
factors and the phases of corneal stromal wound repair. We hypothesize that the
process involves sequential signaling, resulting first in proliferation, followed by
extracellular matrix (ECM) synthesis.
Methods: The effect of IGF-I, TGF-β1, FGF-2, and PDGF on proliferation and
ECM production by primary cultured bovine keratocytes was evaluated. DNA
synthesis was determined by 3H-thymidine incorporation and maximal cell
density was determined by measuring the DNA content. Relative levels of ECM
components synthesized by keratocytes and secreted into the media was
evaluated by 3H-glycine incorporation into total ECM protein and collagen, by 3Hglucosamine incorporation into chondroitin sulfate, keratan sulfate, and
hyaluronan, and by western blots with antibodies specific to procollagen types Ι
and ΙΙΙ.
Results: FGF-2 stimulated the highest level of proliferation, the lowest level of
glycosaminoglycan synthesis, and inhibited the synthesis of collagen collagen
types Ι and ΙΙΙ. IGF-I, in contrast, stimulated the lowest level of proliferation and
the highest levels of collagen synthesis. PDGF and TGF-β1 had intermediate
effects on proliferation and collagen synthesis. Although FGF-2 inhibited
collagen production, it could be restored by subsequent treatment with IGF-I,
TGF-β1, and PDGF.
Conclusions: The results of this study showed that the levels of proliferation
induced by the growth factors were inversely related to the level of collagen
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production. We suggest that FGF-2 initiates the hypercellular phase of corneal
wound healing, while IGF-I and PDGF are involved in the restoration of a normal
ECM.

Introduction
The mature corneal stroma consists of a distinctively organized and
transparent extracellular matrix (ECM) which is comprised of mainly fibrillar
collagen types Ι and V, and three of small leucine-rich proteoglycans; one with
chondroitin sulfate chains (decorin) and two with keratan sulfate chains (lumican
and keratocan). Collagen is present in the corneal stroma as fibrils that are
separated by small spaces containing proteoglycans and are arranged in
plywoodlike layers. Collagens play a fundamental role in the structure and
function of the cornea. The organization of fibrils and lamellae, as well as the
crosslinking of the collagen provide the cornea with its tensile strength while the
uniform diameter and spacing of the collagen fibrils provide the cornea with its
ability to transmit light onto the retina [for reviews see [2, 54, 55]. Collagen type
V initiates fibril formation and acts in conjunction with lumican and keratocan and
decorin to regulate fibril diameter growth [3, 6, 56-59]. Type ΙΙΙ collagen also has
been reported to be normally present in bovine and rabbit corneas [60, 61]. More
recent studies in mice suggest collagen type ΙΙΙ may be developmentally
regulated and expressed primarily in neonatal corneas [62].
Embedded in this unique ECM are keratocytes, neural crest-derived cells
that produce the proteoglycans and collagens [63]. Keratocytes are

19

characterized by a dendritic morphology and form a three-dimensional network in
contact with one another by their extensive processes [63, 64]. Keratocytes
proliferate and are biosynthetically active during corneal development. In adult
corneas, they are considered quiescent because they are locked in G-0 of the
cell cycle [65] and they have a low level of proliferation and matrix synthesis [54,
63, 66]. Keratocytes also are characterized by high levels of crystallins
(aldehyde dehydrogenase and transketolase) in their cytoplasm, which are
proteins that are thought to provide cellular transparency [67].
The cornea’s ability to remain transparent can be compromised when the
cornea encounters trauma, infection, ulceration, or chronic corneal inflammation.
Upon injury, damaged keratocytes and keratocytes flanking the wound undergo
apoptosis [66, 68]. Some of the remaining keratocytes are stimulated to lose
their quiescence and transition into divergent or “activated” phenotypes, which
proliferate, resulting in regions of hypercellularity that then go on to produce the
new matrix needed to repair the wound [4, 66, 69, 70]. These divergent
phenotypes can either aid in regeneration of a normal stromal matrix or become
a scar by remaining hypercellular or producing a disorganized matrix [47, 71]. It
has been proposed that an altered ratio of collagen types and proteoglycans in
the ECM and/or the loss of the “crystallins” from the keratocytes cause the
opacity [48, 49, 67, 72].
Peptide growth factors, extracellular signal proteins (ligands), which
promote the growth, proliferation, and differentiation of cells in animal tissues by
interacting with cell-surface receptors are partially credited for the regulation of
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collagen and proteoglycans expression during corneal wound healing [73].
Growth factors are able to reach the wound site through tear film, aqueous fluid,
and the epithelial layer of the cornea [73] [74, 75]. Insulin-like growth factor-II
(IGF-II) has been shown to be present in the aqueous humor and in the cornea
[38, 76]. Both insulin-like growth factor-I (IGF-I) and IGF-II, which act on the
same receptors, have been shown to cause keratocytes to proliferate and
maintain their dendritic morphology in vitro [38, 75]. Transforming growth factorbeta (TGF-β), fibroblast growth factor-2 (FGF-2), and platelet-derived growth
factor (PDGF) have all been found in tear fluid [51, 52]. These growth factors can
activate keratocytes to proliferate, differentiate into fibroblasts or myofibroblasts,
and migrate, similar to that of in vivo keratocyte response to injury [69, 75, 77,
78].
Although a number of studies have reported the effect of growth factors on
keratocyte morphology, crystallin content, alpha smooth muscle actin expression,
and proteoglycan synthesis [35, 36, 38, 75, 77, 79-81]; comparatively, little
attention has been given to their effect on collagen synthesis [37, 82], which is
the single most important structural element of the cornea. Consequently, in this
study, we analyzed the effects of different growth factors (IGF-I, TGF-β1, FGF-2,
and PDGF) on keratocyte proliferation and matrix synthesis to test our
hypothesis that stromal wound healing involves sequential signaling leading to
keratocyte proliferation followed by extracellular matrix synthesis and deposition.
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Materials and Methods
Chemicals, growth factors, papain, and hyaluronate lyase were purchased
from Sigma-Aldrich (St. Louis, MO) unless otherwise stated. Isotopes were
purchased from Perkin Elmer (Boston, MA). CyQuant kit, gels, reagents, and
equipment that were used for protein separation and transfer were purchased
from Invitrogen (Carlsbad, CA). Endo-beta-galactosidase and chondroitinase
ABC were purchased from Associates of Cape Cod (East Falmouth, MA)
Collagenase Form III for measuring 3H-glycine incorporation into collagen was
purchased from Advanced Biofactures Corp. (Lynbrook, NY)

Keratocyte isolation and culture
Bovine keratocytes were collagenase-isolated as previously described [35,
50]. In brief, freshly harvested corneas were obtained from 12-month old calves
and sequentially digested. Initially, the tissue was subjected to a 45-minute
collagenase digestion to remove the endothelium and epithelium and then
keratocytes were released from the stroma by a second 150-minute digestion.
Keratocytes were plated in serum- free DMEM/F12 containing antibiotics and
1mM 2-phospho-ascorbic acid at 20,000 cells/cm2 to allow attachment (day 0)
and incubated at 37°C with 5% CO2. Medium was changed the next day (day 1)
and every third day thereafter with DMEM/F12 or DMEM/F12 supplemented with:
10 ng/ml IGF-I, 2 ng/ml TGF-β1, 10 ng/ml FGF-2, or 10 ng/ml PDGF-BB.
Cultures were harvested on days 1,7,10, and 13.
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DNA content
DNA was extracted from the cell layers of each well of harvested cultures
using cyquant buffer. DNA in the extract was measured using a Cyquant Assay
Kit consistent with the manufacturer’s instructions and expressed as ng
DNA/well. Calf thymus DNA was used as a standard.

Radiolabeling of keratocytes
Keratocytes were incubated with 10 µCi/ml 3H-thymidine for DNA
synthesis or 25 µCi/ml 3H-glycine for protein/collagen synthesis, beginning on
days 4, 7, and 10 then harvested 3 days later. Keratocytes were also incubated
with 25 µCi/ml 3H-glucosamine for glycosaminoglycan synthesis beginning on
day 7 and harvested on day 10.
DNA synthesis. Incorporation of 3H-thymidine into DNA was determined as
previously described [35]. In summary, aliquots of cyquant buffer extract of the
cell layer was adjusted to contain 10% trichloricacetic acid (TCA), carrier protein
bovine serum albumin (BSA) was added and the mixture held at 4°C overnight to
precipitate DNA. The precipitate was collected onto glass filters and the
unincorporated isotope was removed by washing with ice-cold 5% TCA.
Incorporation was measured by liquid scintillation counting and expressed as
counts per minute/ng DNA.
Protein/collagen synthesis. Incorporation of 3H-glycine into collagen and total
protein secreted into the media was measured as previously described [12].
Briefly, unincorporated radioactivity was removed by chromatography on PD-10
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columns in 4 M guanidine-HCl. The guanidine was removed by dialysis against
water. Aliquots of 400 µl were incubated with 1mg of papain in papain digestion
solution (PBS containing 10mM cysteine and 10mM EDTA) then, digested for 3
hours at 55°C, precipitated with 10% TCA and the supernatant counted to
determine incorporation of 3H-glycine into total protein. Additional 400 µl aliquots
were digested with collagenase at 37°C for 3 hours in collagenase digestion
solution (3 mM N-ethly maleimide, 50 mM Tris, 150 mM NaCl, and 5 mM CaCl2)
and processed as described for papain digests, to determine incorporation into
collagen. The incorporated radiolabeled radioactivity in collagen and in total
protein were expressed counts per minute/ng DNA.
Glycosaminoglycan synthesis. Incorporated 3H-glucosamine secreted in the
medium was isolated by chromatography on PD-10 columns in 4 M guanidine
and dialyzed against distilled water overnight. Aliquots were digested with: H2O
(blank), chondroitinase ABC (.05 U/µl), endo-beta-galactosidase (.5 mU/ µl), and
hyaluronate lyase (ampule dissolved in 250 µl of H2O, used 5 µl/sample), for 3
hours at 37°C. Undigested GAGs were precipitated out by the addition of 2%
dextran sulfate and 1% KAc in 95% ETOH at 4°C. The precipitate was removed
by centrifugation and the radioactivity of the supernatant was measured by liquid
scintillation spectrophotometry. Chondroitinase ABC digests both CS and HA,
therefore, the amount of HA was subtracted from the amount of CS to determine
CS content. The incorporated radioactivity in CS, KS, and HA was expressed per
µg DNA.
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SDS/PAGE/Simply-blue stain
Medium was collected from each condition and concentrated 10-fold using
10 000 MWCO Amicon Ultra spin-concentrators (Millipore Corp., Millford, MA).
Samples were loaded based on DNA content and electrophoresed under
reducing conditions on 3-8% tris-acetate acrylamide gels. Gels were stained with
Simply Blue Safe Stain according to the manufacturer’s instructions.

Pepsin digestion
Eight milliters of medium pooled from 4 wells was adjusted to 0.5 M acetic
acid by the addition of 230 µl of glacial acetic acid. Two milliliters of 0.5 M acetic
acid was added to each of the 4 wells. A pepsin stock solution (4mg/ml of 0.5 N
acetic acid) was prepared and, after the samples had chilled to 4°C, 100 µl of the
stock was added to the medium and 25 µl of the stock was added to each well.
The samples were digested overnight at 4°C. The cell layer samples were
combined and 50 µl of pepsin stock was added to the cell layer samples and
digested for an extra 5 hours at 4°C. The samples were adjusted to neutrality
with NaOH to inactivate pepsin. Samples were dialyzed against water,
lyophilized, and reconstituted in 1X LDS sample buffer. Samples were loaded
based on DNA content, determined on parallel cultures, to 3-8% tris-acetate gels
and electrophoresed as described above.
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Western blotting
Proteoglycan levels, fibronectin levels and procollagen levels in the media
were determined by western blot as described previously [35]. Medium was
digested with endo-beta-galactosidase to detect keratocan and lumican core
proteins, or with chondroitinase ABC to detect decorin and biglycan core
proteins. All samples were loaded based on DNA content and electrophoresed
as described above. Proteins were transferred to a nitrocellulose membrane,
and then blocked with I-Block solution. The primary antibodies were added at
4°C overnight: keratocan [50], lumican [50], decorin (DS1, Hybridoma Bank, U.
of Iowa), biglycan (gift from Dr. Larry W. Fisher), extra domain A (EDA)
fibronectin (Accurate Chemical & Scientific Corp., Westbury, NY), fibronectin
(Chemicon International, Temecula, CA), procollagen type Ι (SP1.D8, Hybridoma
Bank, U. of Iowa) or procollagen type ΙΙΙ (US Biological, Swampscott, MA). The
corresponding secondary was added, which is horseradish peroxidase tagged,
and then detected using the ECL detection kit consistent with manufacture’s
instructions.

Statistics
All DNA values were the mean of 3 or 4 determinations. 3H-thymidine
incorporation values were the mean of 4 determinations. 3H-glucosamine
incorporation values were the mean of 3 determinations. All other values shown
were based on a single determination but all experiments were conducted 2 or
more times using different batches of primary cells and the results of a
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representative experiment is shown. Statview Version 5 (SAS Institute, Cary,
NC) was used for statistical comparisons. Samples were analyzed using a
paired t test. Standard error used n>3 and standard deviation was used when
n=3.

Results
Each growth factor stimulated a different rate of keratocyte proliferation.
Cells were incubated with media containing 3H-thymidine for three days,
beginning on days 4, 7, and 10, and incorporation per ng DNA was determined
on days 7, 10, and 13 (Fig. 5A). All of the growth factors significantly stimulated
higher levels of incorporation relative to the control for all three-time points
except for IGF-I on day 10. At day 7, FGF-2 stimulated incorporation the most
and IGF-I the least with TGF-β1 and PDGF stimulating intermediate levels of
incorporation. Incorporation in the FGF-2 treated cultures decreased from day 7
to 10, to be levels lower than that of TGF-β1 and PDGF but still higher than that
of IGF-I. Each of the growth factors stimulated the highest levels of incorporation
on day 7, except TGF-β1, which stimulates the greatest incorporation on day 10.
Growth factors differentially increased keratocyte culture density. The
DNA content of the keratocyte cultures were measured on days 1, 7, 10, and 13
to determine if cultures treated with each of the growth factors increased the cell
number (Fig. 5B). The DNA content of the control on day 1 was not significantly
different from the control on day 7 (data for day 1 control not shown on figure).
The DNA content of the control and growth factor treated cultures were
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significantly different on day 7: FGF-2 was 3.2-fold higher than control, PDGF
was 2.0-fold higher, TGF-β1 was 1.8-fold higher, and IGF-I was 1.6-fold higher.
The DNA content for the control and growth factor treated cultures on days 10
and 13 followed the same pattern as day 7.
Dermal fibroblasts and keratocytes in standard monolayer culture do not
readily remove the N-and C-terminal globular domains on the procollagen they
synthesize. Procollagen cannot form collagen fibrils that would associate with
the cells and as a result, the procollagen is secreted into the media [83, 84]. In
the absence of collagen fibrils, the proteoglycans and other components of the
ECM that associate with collagen fibrils are also secreted into the media.
Therefore, the media was analyzed for the components of the ECM. Each
growth factor stimulated a different level of total ECM protein and collagen
synthesis. Keratocytes were cultured in media containing 3H-glycine for 3 days
beginning on days 4, 7, and 10. The sensitivity of the incorporated radiolabel
secreted into the media to papain and to collagenase was used to determine the
amount of total ECM protein synthesis and collagen synthesis, respectively.
The results show that compared to controls, IGF-I, TGF-β1, and PDGF
stimulated incorporation into total ECM protein from as little as 4.0-fold for TGFβ1on day 7, to as much as 15-fold for IGF-I on day 13. Keratocytes cultured in
IGF-I synthesized the highest levels of total ECM protein; FGF-2 the lowest;
while PDGF and TGF-β1 had intermediate levels of total ECM protein synthesis,
for all three-time points (Fig. 6A). The levels of total ECM protein synthesized by
the keratocytes cultured in IGF-I, TGF-β1, and PDGF increased from day 7 to 10
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and from day 10 to13 and increased the most in the TGF-β1 treated cultures.
The levels of collagen synthesis followed the same pattern as the total ECM
protein synthesis, but was ~20-40% lower (Fig. 6B).
The proteins that were secreted into the medium by keratocytes also were
evaluated by SDS/PAGE/simply-blue staining. Analysis of DNA-normalized
aliquots from day 10 cultures showed that each of the tested growth factors
caused keratocytes to secrete proteins in the medium that produced a similar
banding pattern, but the band intensity was growth factor dependent (Fig. 7).
IGF-I and TGF-β1 treated cultures secreted the most proteins, FGF-2 the least
and PDGF secreted intermediate levels of proteins. Compared to day 10
cultures, the band intensity of proteins in the medium was less in samples from
day 7 cultures and greater in samples from day 13 cultures, but the banding
pattern for each of the growth factors was comparable at all three time points
(data not shown). These results suggest that IGF-I, TGF-β1, PDGF, and FGF-2
stimulate the cells to secrete essentially the same matrix proteins into the media;
however, the expression levels of the proteins are growth factor specific.
The major proteins secreted into the media were identified using western
blotting. We analyzed DNA-normalized aliquots of media harvested at day 10,
for EDA fibronectin, an isoform of fibronectin found after wounding [85], and
fibronectin. Antisera to EDA fibronectin reacted with a single band of 210 kD
present in the media (Fig. 8A). This protein was most abundant in the media of
TGF-β1treated cultures with lesser amounts in the media of cultures treated with
the other growth factors and only trace amounts in media from controls. A
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western blot using an antibody that recognizes all forms of fibronectin, including
EDA fibronectin, indicated that the levels of fibronectin produced by the control
were similar to that of the FGF-2 treated cultures (Fig. 8B). The blue staining
band at 210 kD in Figure 3 is likely to be fibronectin and is identified as FN.
Western blot analysis using an antibody specific for type Ι procollagen on
DNA-normalized aliquots of medium from day 10 of culture, demonstrated that
type Ι procollagen was readily detected in the medium of keratocytes cultured in
IGF-I, TGF-β1, and PDGF (Fig. 9A). When compared to control, IGF-I, TGF-β1,
and PDGF stimulated the production of type I procollagen while FGF-2 inhibited
the production of type I procollagen. The production of type ΙΙΙ procollagen by
growth factor treated cultures also was evaluated by western blot using an
antibody specific for type ΙΙΙ procollagen. Compared to control, type ΙΙΙ
procollagen was stimulated to the greatest extent in cultures treated with IGF-I
and TGF-β1 and was inhibited in cultures treated with FGF-2 (Fig. 9B). The
major blue staining bands that react with these antibodies are identified in Figure
3 as proα1(Ι)(ΙΙΙ) and pNα(Ι)(ΙΙΙ).
Fibril-forming collagen (types Ι and ΙΙΙ) content in the media and cell layer
from day 10 cultures was determined by pepsin digestion and SDS/PAGE/simply
blue staining (Fig. 10). Pepsin readily degrades globular proteins under acidic
conditions, but those regions of collagen molecules that form a stable triple helix
are resistant to this protease. Keratocytes cultured in IGF-I had the highest
levels of fibrillar collagen in the media. TGF-β1and PDGF induced production of
intermediate amounts of collagen deposited into the medium. Medium from FGF30

2 treated cultures had levels of fibrillar collagen similar to that of the control.
Fibrillar collagen associated with the cell layer was seen only in the TGF-β1
treated cultures.
Glycosaminoglycan synthesis by cultured keratocytes in response to the
different growth factors also was evaluated. Cells were radiolabeled with 3Hglucosamine from days 7 to 10 and the glycosaminoglycans secreted into the
media were digested with chondroitinase ABC, endo-beta-galactosidase, or
hyaluronate lyase to determine the relative levels of chondroitin sulfate, keratan
sulfate, and hyaluronan synthesis, respectively. The results show that when
compared to control, cultures treated with TGF-β1 and PDGF synthesized the
highest levels of chondroitin sulfate and FGF-2 the least (Fig. 11A).
Furthermore, cultures treated with PDGF and IGF-I produced the highest levels
of keratan sulfate synthesis while FGF-2 did not stimulate keratan sulfate
synthesis (Fig. 11B). Hyaluronan synthesis was 20-fold higher than the control
in keratocytes cultured in media containing TGF-β1 (Fig. 11C). These data
indicate that the levels of glycosaminoglycan synthesis stimulated by each of the
growth factors generally follows the pattern of total ECM protein synthesis.
Western blot analyses with antibodies to the core proteins of decorin and,
biglycan, or keratocan, and lumican, respectively were performed. Aliquots of
media harvested on day 10 from keratocytes cultured in each of the growth
factors were normalized for DNA content, digested with either chondroitinase
ABC or endo-beta-galactosidase and analyzed (Fig. 12). Decorin and keratocan
production was stimulated by all of the growth factors. Lumican production was
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only stimulated by IGF-I. Biglycan was only detected in media from keratocytes
cultured in TGF-β1.
FGF-2 induced proliferation the most, a hallmark of the initial phase of
wound healing, but inhibited the synthesis of procollagen Ι, which is essential for
a corneal reconstruction. Therefore, we determined if keratocytes that have
been cultured in FGF-2 could still respond to other growth factors that stimulate
collagen synthesis and up-regulate procollagen type Ι synthesis. Keratocytes
were treated with FGF-2 for 7 days, followed by 6 days of treatment with DMEM
F/12, IGF-I, TGF-β1, FGF-2, or PDGF. DNA content of the cell layer and type Ι
procollagen in the medium were determined (Fig. 13). The DNA content of
cultures continually treated with FGF-2 significantly increased from day 1 (C1) to
day 7 (F7), and then declined a small amount from day 7 (F7) to day 13 (F-F).
Compared to continuous culture in FGF-2 (F-F), cultures switched to PDGF (F-P)
and the IGF-I (F-I) had significantly higher DNA content (Fig. 13A). Aliquots of
medium normalized for DNA content were analyzed using western blots with the
antibody to type Ι procollagen (Fig. 13B). Type Ι procollagen levels in the media
of keratocytes treated with FGF-2 for 7 days (F7) and 13 days (F-F) were less
than the controls (C7 and C13) but cultures switched to IGF-I (F-I), TGF-β1 (F-T),
and PDGF (F-P) showed increased type Ι procollagen levels.

Discussion
When the cornea stroma is wounded, injured keratocytes and keratocytes
surrounding the wound undergo apoptosis [66, 86]. Proliferation by some or all
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of the remaining cells would be essential to replace the cells lost due to
apoptosis. The results of this study show, IGF-I, TGF-β1, FGF-2, and PDGF
stimulate different rates of DNA synthesis and different levels of maximal cell
density. FGF-2 treated keratocytes synthesized DNA at the highest rate at the
day seven time point and reached the highest level of maximal cell density.
PDGF treated keratocytes synthesized DNA at a lower rate at the day 7 time
point but then exceeded FGF-2 at the days 10 and 13 time points and eventually
achieved nearly the same cell density as cells treated with FGF-2. Keratocytes
treated with TGF-β1 synthesized DNA at a rate similar to PDGF and achieved
the third highest level of maximal cell density. IGF-I treated keratocytes had the
lowest rate of DNA synthesis and lowest level of maximal cell density. These
results indicate that, for these growth factors the level of maximal cell density
achieved is related to the rate of DNA synthesis induced by that growth factor.
All of these growth factors, however, would be potential candidates for regulatory
roles in controlling proliferation involved in the hypercellular phase of corneal
stromal wound healing.
The synthesis of an ECM containing collagen is essential subsequent to
proliferation in restoring the integrity of the corneal stroma after wounding. The
results of this study show that IGF-I, TGF-β1, and PDGF stimulate significantly
different levels of collagen synthesis; IGF-I stimulated higher levels of collagen
synthesis than did TGF-β1and PDGF. FGF-2 did not stimulate collagen
synthesis. This same pattern was observed in: 3H-glycine labeling for total ECM
proteins and collagenous proteins, simply blue staining of matrix proteins,

33

western blots with antibodies to types Ι and ΙΙΙ procollagen, and levels of
collagenous proteins revealed by pepsin digestion of the medium. The level of
collagen synthesis induced by each of the growth factors is, then, inversely
related to the level of confluence achieved by keratocytes cultured in that growth
factor.
In addition to the collagens, the proteoglycans and glycoproteins play a
major role during wound healing. Keratan sulfate proteoglycans are normally
present in the corneal stroma at high levels and function to direct collagen
assembly. In contrast, hyaluronan is only present in mature corneas during
wound healing and may reduce transparency by disrupting the spacing of
collagen fibrils [4, 87]. We found that while all of the growth factors stimulated
chondroitin sulfate synthesis, FGF-2 stimulated its synthesis the least. FGF-2
was also the only growth factor that did not stimulate keratan sulfate synthesis.
TGF-β1 treatment, however, also stimulated the synthesis of biglycan and
hyaluronan, known markers of ECM scarring [4, 88, 89].
In addition, TGF-β1stimulated the highest levels of EDA fibronectin and
the greatest amount of collagen associated with the cells. Fibronectin is known
to assist in the formation of ECM by enhancing the conversion of procollagen to
collagen [11]. These results suggest that in addition to stimulating the synthesis
of collagens, IGF-I and PDGF also stimulated the synthesis of the collagens,
proteoglycans, and glycoproteins that more closely resemble normal corneal
stromal composition. Therefore, regeneration of normal stroma after injury is
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likely to involve these growth factors while production of a scar-type ECM would
involve TGF-β1.
Although FGF-2 stimulated keratocytes to proliferate at high levels and
also stimulated the production of decorin and chondroitin sulfate, it did not
stimulate the synthesis of collagenous proteins. Western blots, however,
indicated that FGF-2 actually inhibited the synthesis of types Ι and ΙΙΙ
procollagen. The ECM produced by FGF-2 action on keratocytes would consist
of essentially proteoglycans and fibronectin, and without collagen it would lack
tensile strength. We also showed that the FGF-2 mediated inhibition of type Ι
procollagen synthesis could be reversed by subsequent culture in media
containing the growth factors that stimulate collagen synthesis, IGF-I and PDGF,
growth factors that also stimulate the synthesis of the normal proteoglycans. This
indicates that the inhibition of type Ι procollagen synthesis by FGF-2 was not a
permanent phenotypic change.
In conclusion, we suggest that stromal wound healing occurs as a result of
the sequential action of growth factors on keratocytes (Fig. 14). Quiescent
keratocytes are activated to proliferate upon wounding to create regions of
hypercellularity that consist of densely packed cells with a sparse or provisional
matrix that contains keratocan [30, 70, 71]. We found that while FGF-2
stimulated proliferation and chondroitin sulfate synthesis, it did not stimulate
keratan sulfate synthesis and it inhibited procollagen types Ι and ΙΙΙ synthesis.
This low level of total ECM synthesis by FGF-2 activated keratocytes would
result in a sparse matrix.
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Thus, we speculate that the regions of hypercellularity that are seen
during the initial phases of wound healing are keratocytes that have been
activated by FGF-2. In vivo, the provisional matrix in regions of hypercellularity
can be replaced by a fibrillar matrix. We also observed that collagen synthesis
can be restored to FGF-2 activated keratocytes by subsequent culture in media
containing IGF-I, TGF-β1, and PDGF. Thus, we further speculate that IGF-I or
PDGF could be acting on the hypercellular keratocytes to make them become
collagenous keratocytes. These collagenous keratocytes replace the provisional
matrix with a normal fibrillar matrix that restores stromal integrity and then the
keratocytes later become quiescent again. TGF-β1 also restored collagen
synthesis to FGF-2 activated keratocytes but this growth factor also stimulated
the synthesis of biglycan and hyaluronan, markers of fibrosis.
We propose; therefore, that TGF-β1would cause the hypercellular
keratocytes to become fibrobrocollagenous keratocytes and produce a scar-type
fibrillar matrix. TGF-β1has also been shown to cause keratocytes to become
myofibroblasts, based on the appearance of α smooth muscle actin [36].
Keratocytes made myofibroblastic by TGF-β1would be synonymous with
fibrocollagenous keratocytes. The absence of any subsequent growth factor
would result in a hypercellular scar. The targeted modulation of these signaling
molecules has considerable clinical relevance.
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Figure 5. Keratocyte DNA Synthesis and cell density. Keratocytes were cultured in
DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-I, TGF-β1, FGF-2, or
PDGF. A: Keratocyte DNA Synthesis. Cultures were radiolabeled with 3H-thymidine
on days 4-7, 7-10, and 10-13, the incorporation determined and expressed per ng
DNA. Compared to control, IGF-I, TGF-β1, FGF-2, and PDGF significantly (p<
0.011) increased 3H-thymidine incorporation at all three-time points, except for IGF-I
on day 10. B: Keratocyte Density. DNA content of keratocyte cultures measured on
days 7,10, and 13. Keratocytes cultured with IGF-I, TGF-β1, FGF-2, and PDGF
contained significantly (p<0.044) more DNA than the control, for all three-time points.
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Figure 6. Protein and collagen synthesis by keratocytes in culture. Keratocytes
were cultured with DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-I,
TGF-β1, FGF-2, or PDGF and radiolabeled with 3H-glycine on days 4-7, 7-10, and
10-13. The sensitivity of the incorporated radiolabel secreted in the media to
papain (A: Total Protein) and to collagenase (B: Collagenous protein) was
determined and expressed per ng DNA.
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Figure 7. Simply-blue stainable proteins secreted into the medium by keratocytes
in culture. Keratocytes were cultured with DMEM/F12 (Control) or DMEM F/12
supplemented with IGF-I, TGF-β1, FGF-2, or PDGF. The medium from the 7-10
day time period was harvested and analyzed by SDS/Page. The bands later
identified by western blot in Figs 4 and 5 are labeled: fibronectin [FN], procollagen I
[proα1(Ι) and pNα1(Ι)], and procollagen ΙΙΙ [proα1(ΙΙΙ) and pNα1(ΙΙΙ)].
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Figure 8. Western blots of media from day 10 keratocyte cultures using
antibodies to EDA fibronectin for EDA fibronectin (A) and to fibronectin for total
fibronectin (B). Keratocytes were cultured with DMEM/F12 (Control) or DMEM
F/12 supplemented with IGF-I, TGF-β1, FGF-2, or PDGF. The bands detected by
these antibodies correspond to the bands marked FN on figure 3.
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Figure 9. Western blots of media from day 10 keratocyte cultures using antibodies to
procollagen type Ι (A) and procollagen type ΙΙΙ (B). Keratocytes were cultured with
DMEM/F12 (Control) or DMEM F/12 supplemented with IGF-I, TGF-β1, FGF-2, or
PDGF. The bands marked proα1(Ι), proα1(ΙΙΙ), pNα1(Ι), and pNα1(ΙΙΙ), corresponds
to the migration position of the band marked proα1(Ι)(ΙΙΙ) and pNα1(Ι)(ΙΙΙ) on figure 3.
The migration position of pepsin digested collagen types Ι and ΙΙΙ are marked as
α1(Ι),α2(Ι), and α1(ΙΙΙ), respectively.
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Figure 10. Fibrillar collagen present in the medium and cell layer of day 10
keratocyte cultures. Keratocytes were cultured with DMEM/F12 (Control) or
DMEM F/12 supplemented with IGF-I, TGF-β1, FGF-2, or PDGF. Cultures were
harvested on day 10 and samples were digested with pepsin prior to
electrophoresis. A pepsin alone control was added (Pepsin). The migration
position of the α1(Ι), α2(Ι) and α1(ΙΙΙ) chains of collagen are marked.
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Figure 11. Glycosaminoglycan synthesis by keratocyte cultures. Keratocytes
were cultured with DMEM/F12 (Control) or DMEM F/12 supplemented with IGFI, TGF-β1, FGF-2, or PDGF and radiolabeled with 3H-glucosamine on days 7-10.
The incorporated radiolabel secreted in the media was then characterized by its
sensitivity to chondroitinase ABC for chondroitin sulfate (A), to endo-betagalactosidase for keratan sulfate (B), and hyaluronan lyase for hyaluronan (C).
When compared to control, the synthesis of chondroitin sulfate (A) was
significantly (p<0.008) higher in cultures treated with each of the growth factors;
keratan sulfate (B) was significantly (p<0.012) higher in TGF-β1, FGF-2, and
PDGF treated cultures; and hyaluronan (C) was significantly (p<0.05) higher in
cultures treated with TGF-β1, FGF-2 and PDGF.
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Figure 12. Western blots of medium from day 10 keratocyte cultures
using antibodies to decorin, biglycan, keratocan, and lumican.
Keratocytes were cultured with DMEM/F12 (Control) or DMEM F/12
supplemented with IGF-I, TGF-β1, FGF-2, or PDGF. Media was digested
with chondroitinase ABC, for decorin and biglycan, or endo-betagalactosidase, for keratocan, and lumican, prior to electrophoresis.
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Figure 13. DNA content and procollagen type Ι production of keratocytes
cultured first with FGF-2 and then changed to each of the growth factors.
Keratocyte were cultured with FGF-2 for 7 days (F7), then medium was changed
to DMEM F/12 (F-C) or DMEM F/12 supplemented with IGF-I (F-I), TGF-β1 (F-T),
FGF-2 (F-F), or PDGF (F-P) and the keratocytes cultured for 6 additional days.
Keratocytes cultured with DMEM/F12 on days 1 (C1), 7 (C7), and 13 (C13) were
used as controls. A: Keratocyte density. DNA content of keratocytes cultured
with FGF-2 for 7 days was significantly (p<0.0001) higher than the day 7 control.
Keratocytes cultured in FGF-2 for 7 days and then switched to PDGF (F-P) or to
IGF-I (F-I) had significantly (p<0.025) higher DNA content than keratocytes
continuously cultured in FGF-2. B: Procollagen type Ι. Western blot using an
antibody to procollagen type Ι of media harvested on days 7 and 13 of culture.
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Figure 14. Schematic representation of possible growth factor mediated wound
healing of the corneal stroma. Upon wounding, quiescent keratocytes are
activated by FGF-2 to become hypercellular: keratocytes that proliferate and
synthesize a provisional matrix, a matrix that lacks collagen but contains
proteoglycans and fibronectin. The hypercellular keratocytes can be stimulated
by IGF-I or PDGF to become collagenous keratocytes and synthesize a normal
collagenous matrix abundant in collagen type Ι and keratocan. In this case,
collagenous keratocytes eventually become quiescent. Hypercellular keratocytes
can also be stimulated by TGF-β1to become fibrocollagenous keratocytes and
produce an ECM scar, rich in EDA fibronectin, biglycan, and hyaluronan. In
addition, without subsequent activation by other growth factors, hypercellular
keratocytes can remain hypercellular, which give rise to a hypercellular scar.
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Abstract
The transparency of the corneal stroma extracellular matrix (ECM) is
attributed to the unique arrangement and size of the collagen fibrils. Previous
studies have shown that the processing of procollagen to collagen fibrils by
keratocytes cultured in insulin is enhanced by an agarose overlay. We compared
collagen processing by keratocytes treated with IGF-I, TGF-β, FGF-2, and PDGF
in cultures with or without an agarose overlay.
Collagenase-isolated bovine keratocytes from bovine corneas were plated
at 40,000 cells/cm2 and then cultured with DMEM/F12 alone, or DMEM/F12
supplemented on day 4 with either 10ng IGF-I, 2ng TGF-β, 10ng FGF-2, or 10ng
PDGF/ml. Cultures were maintained as standard cultures or overlayed with
~1mm of 3% agarose on day 6 and harvested for analysis on days 20. Pepsin
digestion and was used to determine procollagen deposited into the media and
collagen content of cell layer. Distribution of collagen type I and fibronectin in the
ECM of the agarose cultures was determined by immunofluorescence. Collagen
fibril size and orientation was evaluated by electron microscopy.
Only 6% of the collagen was processed in standard cultures for
keratocytes cultured in media containing IGF-I and PDGF, and the agarose
overlay increased processing 6-fold to 31%. Collagen processing for FGF-2 was
at ~10% with or without agarose. TGF-β treated keratocytes processed 19% of
the collagen in standard culture and agarose increased processing to 31% but it
was not a significant increase. Immunoflourescence staining for collagen type I
and fibronectin in the ECM were in different patterns for all growth factors, which
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suggests they do not co-distributed. Electron microscopy showed that the FGF-2
agarose cultures had little collagen fibrils and the keratocytes were in close cell
contact while IGF-I, TGF-β, and PDGF agarose cultures had an extensive ECM
with abundant collagen fibrils. The results of this study indicate that the
synthesis of procollagen and the processing of procollagen to collagen are
independently regulated and growth factor specific.

Introduction
The avascular cornea functions as a major refractive element of the eye.
The stroma is 90% of the thickness of the cornea and it consists of a uniquely
transparent extracelllular matrix (ECM) and keratocytes. The stromal ECM is
comprised primarily of collagen types I and V that arranged in uniformly sized,
and spaced fibrils with keratan sulfate proteoglycans (keratocan and lumican) or
chondroitin sulfate proteoglycans (decorin) between the fibrils [54, 90-92]. The
highly organized ECM is synthesized and secreted by keratocytes, which are
dendritic in morphology and are sparsely scattered among the stroma [93, 94].
The transparency of the cornea is due to the precise arrangement of the collagen
fibrils in the ECM [55]. This arrangement can be disrupted and transparency can
be compromised upon wounding [4, 5, 72].
Although the keratocytes readily proliferate and are biosynthetically active
during corneal development, they exhibit a relatively low level activity in the adult
cornea and are considered “quiescent” [7, 8, 66]. However, the keratocytes
become active again when a wound occurs to the cornea stroma. The
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keratocytes damaged during wounding undergo apoptosis [66, 68]. Some of the
viable remaining keratocytes are activated to proliferate and migrate to the
wound site [66, 69, 95] to form regions of hypercellularity [70, 96, 97]; densely
packed cells with only a sparse or “provisional” ECM. The keratocytes can
remain hypercellular, resulting in a hypercellular scar or, can go on to stratify by
producing an extensive collagenous ECM that is either a normal ECM which
restores transparency or an abnormal fibrotic ECM, which is opaque [4, 72, 98,
99]. Thus, keratocytes first go through a proliferative, ECM deficient
hypercellular phase that is then followed by either a collagenous phase or a
fibrocollagenous phase that produces keratocyte stratifcation.
We found that the phases of ECM synthesis seen during wound healing in
vivo could be replicated by the action of FGF-2, IGF-I, TGF-β, and PDGF on
keratocytes in vitro [100]. FGF-2 stimulated the highest level of proliferation and
maintained proteoglycan synthesis but did not stimulate collagen synthesis. IGFI, TGF-β, and PDGF, in contrast, stimulated high levels of collagen and
proteoglycan synthesis. TGF-β also stimulated hyaluronan, biglycan, and
fibronectin synthesis, components of the fibrotic ECM. Therefore, we proposed
[100] that in wound healing; 1) FGF-2 would induce the hypercellular phase,
producing the sparse, collagen deficient, provisional matrix, 2) the action of IGF-I
and PDGF would then induce the collagenous phase, producing the normal
stromal ECM that restores transparency or 3) the action of TGF-beta would
induce the fibrocollagenous phase, producing the opaque ECM that causes
blindness.

50

Collagen is first made as procollagen: three polypeptides containing Nand C-terminal globular domains with glycine-rich central region that forms a
triple helix [11]. In vivo, the globular domains are rapidly removed allowing the
helical regions to associate and form collagen fibrils. Fibroblasts in standard cell
culture do not readily process procollagen to collagen [83]. As a result, the
procollagen accumulates in the culture medium and very little collagen is
assembled into an ECM associated with the cells. We have found, however, that
a 3% agarose overlay on keratocytes cultured in insulin increased collagen
processing and the formation of an ECM associated with the keratocytes [84]. In
the current study, we use this agarose overlay cell culture system to compare
collagen processing and ECM assembly by keratocytes cultured in each of the of
growth factors that induce the different phases of cornea stromal wound repair.

Materials and Methods
All chemicals and growth factors were purchased from Sigma-Aldrich (St.
Louis, MO) unless otherwise stated. CyQuant kit, DMEM F/12, polyacrylamide
gels, as well as pre-cast polyacrylamide gels and reagents that were used for
protein separation and transfer were purchased from Invitrogen (Carlsbad, CA)
and ECL Western blot analysis system was purchased from GE Healthcare
(Piscataway, NJ). Costar cell culture plates, nunc 96 well plate and chamber
slides were purchased from Fisher Scientific (Suwanee, GA). Rabbit polyclonal
antibodies to collagen type I were obtained from Cosmo Bio Co. (Tokyo, Japan)
and to fibronectin from Chemicon International (Temecula, CA). FITC
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conjugated anti rabbit antibodies were obtained from Novus Biologicals (Littleton,
CO). A mouse monoclonal antibody to fibronectin and an alkaline phosphotase
conjugated goat anti mouse second antibody was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA) for use in enzyme-linked immunosorbent assay.

Keratocytes isolation and culture
Bovine eyes harvested from 12-month calves were purchased from Pel
Freeze (Rogers, AR) and keratocytes were isolated as previously described [50].
Briefly, corneas were removed and keratocytes isolated by using two sequential
collagenase digestions. The culture medium used throughout was serum-free
DMEM/F12 containing antibiotics and 1mM 2-phospho-ascorbic acid (DMEM).
Cells were plated at ~400,000 cells/well in six well plates; ~200,000 cells/well in
gelatin coated, 2-well slides; and ~1,000,000 cells/ 60 mm dish on day 0. The
medium was changed on day 4 with DMEM or to DMEM supplemented with 10ng
IGF-I, 2ng TGF-β, 10ng FGF-2, or 10ng PDGF/ml.
Keratocyte cultures were overlayed with 3% agarose in DMEM on day 0
as previously described [84]. In brief, 3 grams of agarose in 50 mls of distilled
water was autoclaved, cooled to 37 °C and mixed with an equal volume of 37°C
2x DMEM. The medium was removed from cultures and the cells were
overlayed with a volume of 3% agarose sufficient to produce a layer ~1mm thick
on top of the cells. The agarose was allowed to solidify at room temperature.
DMEM supplemented with 10ng IGF-I, 2ng TGF-β, 10ng FGF-2, or 10ng
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PDGF/ml was then added to the respective wells. Cultures were harvested on
day 20 without intervening media changes.

DNA measurement
DNA was extracted from the cell layers of each well of harvested cultures
using the buffer supplied in a Cyquant Assay Kit and the DNA measured using
methods provided with the kit. Calf thymus was used as a standard.

Collagen measurement
Medium and cell layer of cultures were pepsin digested as previously
described [84, 100] to isolate collagen. Briefly, eight milliliters of culture medium
from a single well of a six well plate was adjusted to 0.5 M acetic acid. Eight
milliliters of 0.5 M acetic acid was added to the corresponding well. After
samples were chilled to 4°C, 100 µl of 4mg/ml pepsin stock was added to the
medium and to each well. The samples were digested overnight at 4°C,
neutralized to inactivate the pepsin, dialyzed against distilled water, lyophilized,
and reconstituted in 100 µl of 1X LDS sample buffer (Invitrogen). Samples of 10
µl were reduced and electrophoresed on 3-8% tris-acetate gels. Gels were
soaked in Simply blue safe stain according to the manufacturer’s instructions
(Invitrogen) to stain the collagen. The lanes were scanned and the optical
density of the α and β chains of collagen was measured using Quantity One.
Collagen for use as standard in SDS/PAGE analysis, was also isolated
from corneas by pepsin digestion, and specifically precipitated by dialysis against
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cold distilled water. The precipitated collagen was solubilized in 0.01N HCl and
quantified by measuring its absorbance at 228 nN.

Fibronectin measurement
Fibronectin levels in the media were determined by enzyme-linked
immunosorbent assay using 96 well nunc plates. Media from cell cultures and
fibronectin used as standard were coated on the wells in bicarbonate buffer. The
wells were blocked with phosphate buffered saline (PBS) containing 1% bovine
serum albumin. The primary and alkaline phosphotase conjugated second
antibody was diluted in PBS with 0.5% tween-20. P-nitophenyl phosphate in
diethanolamine was used as a substrate for color development and optical
density was measured at 405 nm in a 96 well plate reader.

Fixation and immunohistochemistry
Cells on glass slides were fixed in 4% paraformaldehyde in PBS for 1 hr
and rinsed with 1% glycine. The agarose layer was removed and nonspecific
antigens were blocked with 2.5% BSA in PBS at room temperature. Slides were
then incubated with a rabbit anti-bovine collagen type I antibody at 1:500 or rabbit
anti-bovine fibronectin at 1:1000 in dilution buffer (1% BSA, 1% Tween 20 in 1x
PBS) for 2 hrs. Unbound antibody was washed off with two 5-minute washes in
PBS/Tween 20. The primary antibodies were detected by FITC conjugated antirabbit antibody at 1:500 in dilution buffer incubated for 1 hour in the dark.
Afterward, slides were given two 5-minute washes with PBS in the dark. Slides
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were allowed to dry. Cover slips were mounted with DAPI mounting medium,
which stain the nuclei of all cells. Slides stained with the secondary antibody
only were used to determine the levels of background fluorescence for recording
digital images on slides stained with both primary and secondary antibodies.
Positive controls were sections of fresh bovine corneal tissue.

Fixation and electron microscopy
Transmission electron microscopy was used to evaluate the organization
of ECM deposited by keratocytes cultured under agarose. Keratocytes cultured
in 60mm plates were fixed in 2.5% glutaraldehyde, 4% paraformaldehyde, 0.1M
sodium cacodylate, and 8.0 mM calcium chloride. The agarose overlay was
removed and cultures were post-fixed with 1% osmium tetroxide. The samples
were dehydrated with a graded series of ethanol/water solutions. Cells were
scrapped off the dish with a cell scraper, transferred to a 1.5ml tube, further
dehydrated with pure propylene oxide and then infiltrated and embedded in a
mixture of Embed 812, nadic methyl anhydride, dodecenylsuccinic anhydride and
DMP-30 (Electron Microscopy Sciences, PA). Sections of 90nm thickness were
examined using a JEOL 1400 transmission electron microscope, and
photographed with a Gatan Orius camera.

Statistics
All DNA and collagen values were the mean of 3 determinations. Statview
Version 5 (SAS Institute, Cary, NC) was used for statistical comparisons.
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Samples were analyzed using a paired t test and standard deviation was used
when n=3.

Results
Keratocytes were cultured for days 4 to 20 in media containing IGF-I,
TGF-β, FGF-2 or PDGF in standard culture and with an agarose overlay. The
cultures were harvested on day 20 and the fibrillar collagen deposited with the
cell layer was solubilized by pepsin digestion. The collagen in the pepsin
digestion was measured by SDS/PAGE and the amount of collagen was
expressed per DNA. IGF-I and PDGF agarose cultures accumulated significantly
more collagen with the cell layer in agarose cultures than in standard culture by
2.8-fold (Fig. 15). In contrast, standard and agarose keratocyte cultures treated
with TGF-β and FGF-2 had similar levels of collagen associated with the cell
layer, although TGF-β cultures accumulated significantly more collagen than
FGF-2 by 6-fold. These results indicate that the agarose overlay significantly
enhanced collagen deposition with the cell layer in keratocytes cultured in media
containing IGF-I and PDGF.
In vivo, procollagen, a precursor of collagen is readily processed and
subsequently assembled into mature collagen fibrils [11]. However, in standard
cell culture, procollagen is not efficiently processed and it accumulates in the
media as procollagen [83, 84]. We used pepsin digestion to convert the
procollagen in the media to collagen to make it compatible with measurement of
collagen levels in the cell layer. Cultures treated with IGF-I, TGF-β, and PDGF
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and overlayed with agarose had significantly lower (45-55% lower) levels of
collagen in the media than the standard cultures (Fig. 16). This indicates that
procollagen secretion into the media was significantly reduced by the agarose
overlay for keratocytes cultured in all growth factors except FGF-2.
The amounts of collagen in the media and cell layers were then combined
to determine total collagen produced in standard and agarose cultures treated
with growth factors (Fig. 17). Keratocytes cultured in media containing IGF-I,
TGF-β, and PDGF produced significantly less (37-39% less) total collagen when
overlayered with agarose. This indicates that the agarose overlay significantly
inhibits collagen synthesis in keratocytes cultured in all growth factors except
FGF-2.
We next calculated the amount of collagen in the cell layer as a percent of
the total collagen (cell layer and media) produced (Fig. 18). The results show
that keratocytes cultured in IGF-I and PDGF in standard culture converted ~6%
of the total collagen produced to fibrillar collagen and this was increased to 31%
(5 –fold) by agarose. Keratocytes cultured in TGF-β in standard culture,
however, converted significantly more (19%) than IGF-I and PDGF in standard
culture and although the agarose increased conversion to 31% for TGF-β, it was
not significantly more. Thus, for keratocytes cultured in TGF-β, the agarose
overlay did not significantly enhance procollagen conversion to collagen over that
achieved in standard cultures because of the already high levels of conversion in
standard culture. Collagen conversion was at ~10% for FGF-2 treated cultures,
with or without agarose. These results indicate the synthesis of procollagen and
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the processing of procollagen are independently regulated and growth factor
specific.
Fibronectin is a component of the ECM that has a molecular weight similar
to procollagen type I. Therefore, we also measured the levels of fibronectin in
the media of keratocytes treated with growth factors and cultured with and
without agarose overlay (Fig. 19). The levels of fibronectin in the media of
keratocytes in standard culture containing PDGF and TGF-β was 5-fold and 38fold higher, respectively, than that for IGF-I or FGF-2 in standard culture.
However, in contrast to that seen with the agarose-mediated reduction of
procollagen in the media, agarose did not reduce the levels of fibronectin
deposited into the media.
The distribution of collagen and fibronectin within the cell layer of the
agarose cultures was determined by immunohistochemistry using rabbit
antibodies to collagen type I and to fibronectin followed by a FITC labeled second
goat anti rabbit antibody (Fig. 20). Nuclei were stained with DAPI. The location
of the nuclei showed that keratocytes tended to cluster in aggregates when
cultured in IGF-I but were more uniformly distributed when cultured in the other
growth factors. The antibody to collagen type I showed that collagen in IGF-I
treated cultures were deposited in linearly connected clumps that corresponded
with the cell aggregates. The collagen deposited in the TGF-β treated cultures
were distributed more uniformly in large homogenous patches. Staining for
collagen in FGF-2 treated cultures was almost non-existent. The collagen in the
PDGF treated cultures was deposited in both intensely staining clumps and in
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faintly staining patches. The antibody to fibronectin revealed fibronectin was
distributed in both thick and thin linear tracks: thick linear tracks in the IGF-I and
PDGF treated cultures, much thinner and more homogeneously distributed linear
tracks in the TGF-β treated cultures and both thick and thin linear tracks in the
FGF-2 treated cultures. Staining for fibronectin was clearly more extensive than
the staining for collagen in the FGF-2 treated cultures.
The size and organization of the collagen fibrils in the ECM of the cell
layer of agarose cultures was determined by transmission electron microscopy.
There was extensive ECM space between cells in the IGF-I, TGF-β and PDGF
treated cultures that was filled with collagen fibrils (Fig. 21). The diameter of
fibrils in the TGF-β treated culture were approximately one half the diameter and
were more uniformly oriented than that seen in IGF-I treated cultures. The fibrils
in the PDGF treated cultures showed the characteristics seen in both the TGF-β
and IGF-I cultures. There was only limited ECM space in the FGF-2 treated
cultures. The keratocytes were densely packed together and the collagen fibrils
in the space between the cells were sparse. The cell surfaces in FGF-2 treated
cultures showed extensive regions of cell-cell contact.

Discussion
The results of these studies shows that compared to standard cultures,
the agarose overlay enhanced collagen accumulation associated with the cell
layer of keratocytes cultured in media containing IGF-I and PDGF but not in
keratocytes cultured in TGF-β. TGF-β, IGF-I and PDGF, all stimulated collagen
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synthesis in standard cultures [100]. The results of the current study, however,
show TGF-β treated keratocytes to be more efficient at processing procollagen to
collagen in standard culture than IGF-I or PDGF and this may account for the
lack of an enhancing effect of the agarose overlay on TGF-β treated keratocytes.
The accumulation of collagen associated with the cell layer was also not
enhanced by the agarose overlay of the FGF-2 treated cultures. FGF-2,
however, does not stimulate collagen synthesis in standard culture [100]. This
suggests that the agarose overlay only can enhance collagen processing when
collagen synthesis is stimulated by some growth factors.
TGF-β has previously been shown to enhance the proliferation and cell
stratification of human fibroblast in standard culture and in media containing fetal
bovine serum [101] and these antibodies to fibronectin could inhibit both the
basal levels and TGF-β stimulated levels of proliferation and stratification. We
found TGF-β stimulated fibronectin synthesis 5 and 20-fold greater than that of
PDGF and IGF-I, respectively and that the distribution of fibronectin in the ECM
of the TGF-β treated cultures, as determined by immunoflourescent staining, was
distinctively different than that of the IGF-I and PDGF treated cultures.
Fibronectin has been shown to play an essential role in the assembly of collagen
types I and III fibrils [102, 103]. The high levels of fibronectin production seen in
TGF-β treated cultures and its unique distribution may be responsible for the high
levels of procollagen to collagen conversion seen in the TGF-β treated
keratocytes in standard culture.

60

The agarose overlay reduced the levels of procollagen, but not the levels
of fibronectin in the media of keratocytes cultured in media containing IGF-I,
TGF-β, and PDGF. We previously proposed [84] that the agarose overlay may
be acting as a semi permeable barrier, or molecular sieve, to retard the diffusion
of procollagen into the media and increase its concentration at the cell surface
where the enzymes are that remove the N- and C-terminal globular domains from
the procollagen. Fibronectin and procollagen have similar molecular weights and
the differential effect that the agarose has on their diffusion into the media would
suggest that the agarose is not acting as a molecular sieve.
The immunostaining for collagen and fibronectin showed they were
deposited with the cell layer in distinctly different patterns for each of the growth
factors. The keratocytes cultured in IGF-I formed aggregates and collagen was
deposited in clumps while the fibronectin was in thick tracks associated with
these cell aggregates. In contrast, the collagen was deposited in large patches
and the fibronectin in thin tracks and both were more uniformly distributed in cell
layer of keratocytes cultured in TGF-β. The pattern of collagen distribution in the
PDGF treated cultures was intermediate between that seen in the IGF-I and
TGF-β treated cultures. Similarly, the pattern of distribution of fibronectin
deposited in the PDGF treated cultures also had characteristics of both the IGF-I
and TGF-β cultures: it was distributed throughout the culture, but it was in thick
bands, like the IGF-cultures. Fibronectin distribution is the FGF-2 treated
cultures was considerably more extensive than that of collagen. These
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observations suggest that the collagen and fibronectin deposited in the ECM of
these cultures do no co-distribute.
Electron microscopy revealed differences in the collagen fibrils that were
deposited in the ECM by keratocytes cultured in the different growth factors. The
fibrils in the IGF-I treated cultures were organized in lamellae while the fibrils in
the TGF-β treated cultures were thinner and were more uniformly oriented.
Although there was abundant fibril deposition in the IGF-I, TGF-β, and PDGF
treated cultures, there was only a few fibrils seen in the FGF-2 treated cultures.
In the FGF-2 treated cultures, the keratocytes were densely packed together with
extensive close cell contacts, leaving little space for an ECM. This is similar to
that seen for keratocytes in the hypercellular phase of corneal stromal wound
healing.
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Figure 15. Collagen levels associated with the cell layer of keratocytes in
standard and in agarose culture. Keratocytes were cultured in media
containing IGF-I, TGF-β, FGF-2, or PDGF and harvested for analysis on
day 20. Agarose overlay significantly enhanced collagen accumulation in
keratocytes cultured in IGF-I and PDGF by 2.8 fold. TGF-β and FGF-2
agarose cultures had similar levels of collagen in the cell layer as the
standard cultures.
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Figure 16. Collagen levels in the media of keratocytes in standard and in
agarose culture. Keratocytes were cultured in media containing IGF-I, TGF-β,
FGF-2, or PDGF and harvested for analysis on day 20. Keratocytes cultured
in media containing IGF-I, TGF-β, and PDGF and under agarose deposited
significantly less collagen into the media than in parallel standard cultures.
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Figure 17. Collagen levels associated with the cell layer and media combined
of keratocytes in standard and in agarose cultures. Keratocytes were cultured
in media containing IGF-I, TGF-β, FGF-2, or PDGF and harvested on day 20.
IGF-I, TGF-β, and PDGF agarose cultures produced significantly less total
collagen than standard cultures.
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Figure 18. Procollagen to collagen conversion rates for keratocytes in standard
and agarose cultures. Collagen amounts associated with the cell layer (Figure 1)
were divided by the amounts in the cell layer and media combined and expressed
as a percent. Compared to standard cultures, agarose significantly enhanced
procollagen conversion to collagen in cultures treated with IGF-I and PDGF by 6fold. TGF-β treated standard cultures were significantly more efficient at
converting procollagen to collagen then IGF-I and PDGF standard cultures by ~3fold.
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Figure 19. Fibronectin levels in the media of keratocytes in standard and
agarose cultures. Keratocytes were cultured in media containing IGF-I, TGFβ, FGF-2, or PDGF and harvested for analysis on day 20. In standard
cultures, keratocytes cultured in TGF-β accumulated ~20-fold more fibronectin
in the media than IGF-I and FGF-2 cultures and 5-fold more fibronectin in the
media than PDGF cultures. However, compared to standard culture, agarose
had no effect on the deposition of fibronectin into the media.
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Figure 20. Immunofluorescent staining of the cell layers of keratocytes cultured
under agarose. Keratocytes were cultured in media containing IGF-I (I), TGF-β
(T), FGF-2 (F), or PDGF (P) and stained with antibodies to either collagen (c) or
fibronectin (f) on day 20. Nuclei were stained with DAPI. Collagen was
distributed in clumps and in large patches while fibronectin was distributed in
thick and thin tracks.
68

I

T

F

P

Figure 21. Electron microscopy of the cell layers of keratocytes cultured under
agarose. Keratocytes were cultured in media containing IGF-I (I), TGF-β (T),
FGF-2 (F), or PDGF (P) and fixed for electronmicroscopy on day 20. Collagen
fibrils were abundant in the ECM of the IGF-I TGF-β, and PDGF treated cultures
while FGF-2 treated cultures exhibited only little ECM with few collagen fibrils.
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Chapter Four
Expansion of Primary Cultures of Keratocyte with Retention of Native
Phenotype
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Introduction
The stroma is the thickest layer of the cornea and consists of a
transparent ECM, comprised mainly of proteoglycans and fibrillar collagens [2].
The ECM is synthesized and secreted by keratocytes. In a mature cornea,
keratocytes are quiescent and dispersed among the stroma, possessing a
dendritic morphology and elevated levels of two keratan sulfate proteoglycans:
lumican and keratocan. These cells also express crystallins, high levels of
aldehyde dehydrogenase (ALDH) and transketolase, which contribute to the
transparency of the cornea [4, 104, 105]. The expression of keratocan and high
levels of ALDH are unique to keratocytes and they are considered markers of
their native phenotype.
The standard culture medium for keratocytes in culture is DMEM/F12
containing 5-10% fetal bovine serum. Fetal bovine serum causes the
keratocytes proliferate and to differentiate into fibroblasts or myofibroblasts [81,
106, 107]. These cells are characterized by their spindle-like morphology,
increased rate of proliferation and expression of fibronectin, hyaluronan, and
alpha-smooth muscle actin, and decreased expression of keratan sulfate
proteoglycans and aldehyde dehydrogenase (ALDH) [80, 88, 106]. It has been
suggested that the corneal fibroblasts and myofibroblasts are not terminally
differentiated and can return to the keratocyte phenotype [108].
Considering the wide spread use of corneal fibroblasts in vision research,
it would be useful if there was a simple way to restore the keratocyte phenotype
to these differentiated cells. Studies have shown that human keratocytes can
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retain their native morphology and keratocan expression in the presence of FBS,
when cultured on an amniotic membrane [109]. Other studies have shown that
KS synthesis and a dendritic morphology but not ALDH content could be restored
to bovine corneal fibroblasts by switching to serum-free medium [110].
Additionally, keratocytes isolated from human corneas, cultured in a special stem
cell medium and selected for a stem cell marker protein become fibroblastic, but
keratan sulfate, keratocan, and ALDH expression could be restored in these cells
by subsequent culture in medium containing FGF-2 and ITS (Insulin, Transferrin,
and Selenium) [111].
In this study, we investigated the effect of media containing either insulin,
ITS, or FGF-2 alone or in combination, on the proliferation and restoration of
keratocan by bovine and human keratocytes. We expect FGF-2 to significantly
stimulate proliferation and ITS and insulin to stimulate keratocan production.

Materials and Methods
The materials and methods used are the same as in Chapter 2.

Results and Discussion
We attempted to grow and pass primary bovine keratocytes by culture in
medium containing either insulin, ITS, FGF-2, or FGF-2 with insulin or ITS. We
found that keratocytes cultured in insulin and ITS could not be removed from the
culture plate by standard trypsin digestion. Keratocytes cultured in FGF-2
proliferated and were efficiently removed and passed, but proliferation
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discontinued after the first or second passage. FGF-2 treated keratocytes
possessed spindled-shape morphology. Keratocytes cultured in FGF-2
combined with insulin or ITS, however, could be repeatedly passed using trypsin
digestion and replated. These cells continued to proliferate and retained their
dendritic morphology when cultured in insulin or ITS.
Therefore, we cultured bovine keratocytes in media containing FGF-2
combined with ITS and passed them 4 times at low density. Keratocytes were
then evaluated for their ability to proliferate and produce keratocan by
subsequent culture for 6 days in media insulin, ITS, or FGF-2 alone or in
combination. The results showed that compared to control, the DNA content of
the keratocytes cultured in FGF-2 alone increased 24% and the DNA content of
the cultures in FGF-2 combined with either insulin or ITS increased 1.6 fold (Fig.
22A).
Media samples were digested with endo β galactosidase to remove the
KS chains from KSPG’s. Then, digested media was DNA-normalized and levels
of keratocan core protein were measured by Western blot using an antibody to
keratocan (Fig. 22B). The results showed that both the control and the FGF-2
treated cultures expressed low levels of keratocan while cultures in FGF-2 plus
insulin or plus ITS expressed higher levels but cultures in insulin or in ITS alone
expressed the highest levels. The keratocytes cultured in insulin or in ITS also reacquired a dendritic morphology (data not shown). This suggests that
keratocytes maintain keratocan expression after growth and passage in media
containing FGF-2 plus ITS. Additionally, keratocytes subsequently cultured in
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insulin or ITS further enhances keratocan expression as well as their dendritic
morphology.
We next determined if keratocan could be restored to cultured bovine
keratocytes passed in fetal bovine serum by subsequent culture in insulin and
ITS alone or in combination with FGF-2. Therefore, we grew keratocytes in
media containing 2.5% FBS and they possessed myofibroblast-like morphology.
The keratocytes were passed 6 times, and plated them at low density. We then
tested their ability to proliferate (Fig. 23A) and produce keratocan (Fig. 23B) by
subsequent culture in media with and without growth factors for 6 days.
Compared to control, the DNA content of the cultures treated with FGF-2 alone
increased 22%. The DNA content of the cultures treated with FGF-2 combined
with insulin increased 1.4-fold, while the DNA content of cultures treated with
FGF-2 combined with ITS increased 5-fold. Levels of keratocan were evaluated
as previously described. We found that the control and the FGF-2 treated
cultures contained undetectable levels of keratocan. Cultures treated with insulin
alone, ITS alone, and FGF-2 combined with ITS contained readily detectable
levels of keratocan. The keratocytes cultured in insulin alone and ITS alone
reacquired a dendritic morphology (data not shown). This data showed that
keratocan synthesis and a dendritic morphology can be restored to keratocytes
passed in FBS by subsequent culture in insulin or ITS.
We next isolated human keratocytes from human corneas and cultured
them in medium containing FGF-2 and ITS. When the human keratocytes are
plated and allowed to attach, they possess a dendritic morphology. Unlike
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bovine keratocytes, the human keratocytes become spindled-shaped after being
cultured in media containing FGF-2 and ITS and passed only once. Thus, while
we were able to grow and pass these human keratocytes in this defined culture
medium, we were unable to detect keratocan by western blot, a hallmark of
native keratocytes.
To assure that our antibodies to keratocan reacted with human keratocan
if present, we extracted keratocan from human corneas and tested the antibodies
by western blot. We found that both the antibody to bovine keratocan and the
antibody we purchased to human keratocan reacted with human keratocan core
protein. Therefore the failure to detect keratocan in media from cultured human
keratocytes is not due to faulty antibodies. The human corneas were from 16,
17, and 42-year-old donors, while the bovine corneas were taken from 1-2
year(s) old cattle. Thus, it may be necessary to isolate keratocytes from corneas
of younger human donors in order to successfully culture human keratocytes that
maintain their in vivo phenotype.

75

Figure 22. Cell growth and keratocan expression by cultures derived from
passed keratocytes. Primary cultures of bovine keratocytes were grown and
passed 4 times in media containing FGF-2 plus ITS. The keratocytes were
then plated at low density and cultured in media containing either FGF-2,
insulin, ITS, insulin + FGF-2, or ITS + FGF-2 for 6 days. A: DNA content of
cell layer. B: Western blot of endo-β- galactosidase digests of media using
an antibody to keratocan core protein.
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Figure 23. Cell growth and keratocan expression by cultures derived from
passed corneal fibroblasts. Primary cultures of bovine keratocytes were
grown and passed 6 times in media containing 2.5% FBS. The corneal
fibroblasts were then plated at low density in media containing either FGF-2,
insulin, insulin + FGF-2, ITS, or ITS + FGF-2 for 6 days. A: DNA content of
cell layer. B: Western blot of endo-β- galactosidase digests of media using
an antibody to keratocan core protein.
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Chapter Five
Conclusions and Future Directions
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When the corneal stroma is wounded the keratocytes become activated
by specific growth factors to proliferate, form regions of hypercellularity (densely
packed cells with little extracellular matrix), and then go on to stratify by
producing an extensive collagenous matrix. These growth factors are made by
macrophages, lymphocytes, and keratocytes themselves. Additionally, growth
factors have also been found to be present in tear film, aqueous fluid, and
epithelium layer of the cornea. Studies have shown that TGF-β is the key growth
factor that aids in wound healing and causes the formation of a scar. We have
found that other growth factors such as, IGF-I, FGF-2, and PDGF are also
important during the corneal wound healing process in vitro.
We grew keratocytes in standard culture and in standard culture with an
agarose overlay. The agarose overlay enhanced the conversion of procollagen
to collagen (Fig. 24), thereby increasing the deposition of collagen fibrils with the
cell layer. We postulated that the agarose overlay was acting as a molecular
sieve. There is no agarose present in vivo, however, the basement membrane
that is made by the corneal epithelium is similar in structure and is likely to have
the same function as the agarose overlay in vitro.
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Figure 24. Agarose overlay enhances the conversion of procollagen to collagen.

Keratocytes were cultured in media containing IGF-I, TGF-β, FGF-2, and
PDGF and compared their ability to stimulate cell proliferation and extracellular
matrix (ECM) synthesis. Distribution and orientation of specific ECM proteins
synthesized by keratocytes cultured in media containing IGF-I, TGF-β, FGF-2,
and PDGF was evaluated by overlaying cells with agarose. We found that FGF2 stimulated the highest level of proliferation but did not stimulate collagen
synthesis. FGF-2 treated keratocytes were in close cell contact. Therefore we
speculated that FGF-2 signaling is associated with the hypercellular phase of
corneal wound healing.
IGF-I, TGF-β, and PDGF all stimulated proliferation and collagen
synthesis. TGF-β also stimulated the highest levels of EDA fibronectin, collagen
type III, hyaluronan, and biglycan, markers of the abnormal fibrotic ECM. IGF-I
and PDGF cultures mostly stimulated collagen type I and keratan sulfate
proteoglycans. TGF-β, IGF-I, and PDGF are likely to be involved in the
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remodeling and stratification phase of corneal wound healing. Presumably, IGF-I
and PDGF are responsible for the restoration of a normal collagenous ECM,
where as TGF-β is involved in the formation of a collagenous scarred ECM. This
sequential action of growth factors is depicted in (Fig. 25).

Figure 25. Proposed sequential action of growth factors to produce the phases
of wound healing

Taken together, the data in this dissertation should help to explain the role
of growth factors in the corneal wound healing process. We have discovered that
IGF-I, TGF-β, FGF-2, and PDGF are likely responsible for stimulating the
different phases of corneal wound healing in vivo based on keratocyte
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morphology and extracellular matrix production. Therefore, we can possibly
direct keratocytes to make a normal collagenous ECM upon wounding by
manipulating the levels of growth factors during specific phases of corneal wound
repair. As a result, we can reduce corneal opacity caused by scarring.
Additionally, these growth factors can be used to stimulate keratocytes to
produce collagen, in collagen-depleted corneas of keratoconus patients.
Therefore, this dissertation is clinically relevant and a significant addition to the
scientific literature. It serves to identify novel targets for treatment of corneal
scarring and keratoconus.
To further this study, we plan to evaluate the levels of these growth factors
in each phase of the corneal wound healing process in vivo. Then, inhibit select
growth factors or use knockout animals to determine the effect on the
morphology of keratocytes and the ECM components. Additionally, we plan to
use the newly established agarose cell culture system to further visualize the
corneal stroma ECM in vitro. More specifically, the agarose cell culture system
will be used to further study the interactions between keratocytes and their
surrounding extracellular matrix as well as to determine the expression of growth
factor receptors during each phase of corneal wound healing.
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Appendix A
Pepsin readily degrades globular proteins, but the triple helical domains of
collagen are resistant to this protease. Aliquots of pepsin digested media and
cell layers, normalized for DNA, harvested from the day 7, 10, and 13 time points
were fractionated on SDS/PAGE and the collagenous proteins visualized by
simply blue staining (Fig. 26). Similar to that seen for the proteoglycans, the
media (M) from the IGF-1 cultures contained substantially higher amounts of the
a1(I), a2(I) and a1(V) chains of collagen than the control cultures and media from
the days 10 and 13 insulin cultures contained slightly higher levels of these
collagens than the IGF-1 cultures. This data demonstrate that insulin and IGF-I
stimulate keratocytes to synthesize similar levels of collagen.

Figure 26. SDS/PAGE/Blue stain of pepsin digests from keratocyte cultures.
Keratocytes were cultured in media alone (C) or in media containing either IGF-I
(IG) or insulin (IN). Cultures were harvested on day 7, 10, and 17. The media
(M) and cell layers (CL) were digested with pepsin prior to electrophoresis.
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